Skip to content
stoqly

Celanese

CE NYSE Specialty Chemicals Financials FY2016–FY2025

Celanese's revenue fell 7.0% to $9.5 billion in fiscal 2025. Its operating margin was −8.2%, down from −7.0% a year earlier. Free cash flow was $803 million, up 51.2%. It paid out $13 million in dividends and buybacks, 2% of free cash flow. The diluted share count rose 0.2%.

Last close · Oct 23, 2026

$47.71

1.0%
Value it Compare
Revenue Total sales reported in the income statement.
$9.5B
7.1% vs prior year
Operating margin Operating income as a share of revenue.
−8.2%
1.2 pts
Net income Profit after all expenses, interest and tax.
−$1.2B
Free cash flow Cash from operations minus capital spending.
$803M
51.2%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
−3.7%
0.6 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$5.3B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
—

About these figures. Net debt to EBITDA for fiscal 2025 is blank: the 10-K's structured data doesn't include every figure it needs.

What Celanese does

No business description yet.

Legal name
CELANESE CORPORATION
Fiscal year ends
December 31, 2025
Latest annual report
—
Accession · CIK
0001306830-26-000031
0001306830

Revenue and margins

Celanese had $9.5B of revenue in fiscal 2025, down 7.1% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $803M in fiscal 2025, 8.4% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Celanese returned $13.0M to shareholders in fiscal 2025, 2% of free cash flow. The diluted share count rose 0.2%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value Celanese yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.

Discounted cash flow

Value per share

—

Adds net cash of −$11.5B and divides by 109.5M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Balance sheet

Cash, debt and the ratios that show how comfortably Celanese can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $546M$1.5B$1.8B$962M$1.3B
Debt incl. finance leases $4.0B$14.6B$13.7B$12.7B$12.8B
Net debt / EBITDA 1.5x7.1x5.0x145.2x—
Debt / equity 1.0x2.6x1.9x2.5x3.2x
Interest coverage 21.4x3.4x2.3x−1.1x−1.1x
Current ratio 1.5x1.6x1.5x1.3x1.6x
Quick ratio 0.9x0.9x1.0x0.7x0.9x
Total assets $12.0B$26.3B$26.6B$22.8B$21.7B
Total liabilities $7.4B$20.2B$19.1B$17.3B$17.2B
Shareholders' equity $4.2B$5.6B$7.1B$5.1B$4.0B
Net debt (− = net cash) $3.4B$13.1B$11.9B$11.8B$11.5B

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.6M

4 insiders

Sold, 12 months

$0.0M

0 insiders

Of sales under plans

—

$0.0M

DateInsiderTradeSharesPriceValueFiling
Aug 14, 2026 Chuck KyrishSVP & CFO Bought 2,300 $45.52 $0.1M Form 4
Aug 11, 2026 Ashley B DuffieSVP & GC Bought 600 $45.60 $0.0M Form 4
Aug 11, 2026 Mark Christopher MurraySVP - Acetyls Bought 2,153 $45.52 $0.1M Form 4
Dec 10, 2025 Scott A RichardsonCEO & President, Director Bought 3,800 $41.59 $0.2M Form 4
Dec 9, 2025 Chuck KyrishSVP & CFO Bought 5,000 $41.03 $0.2M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive ✓ ✕ ✕
Cash from operations is positive ✓ ✓ ✓
Return on assets rose ✕ ✕ ✓
Cash from operations exceeds net income ✕ ✓ ✓
Debt fell relative to assets ✓ ✓ ✕
Current ratio rose ✕ ✕ ✓
Share count didn't rise ✕ ✓ ✕
Gross margin rose ✕ ✕ ✕
Revenue rose relative to assets ✕ ✕ ✓
F-score 3 / 94 / 95 / 9
Accruals ratio 0.2%−10.2%−10.4%
Altman Z'' 2.952.062.12

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
Celanese CE $5.3B −7.1% −8.2% 8.4% −3.7% — 5
Eastman Chemical EMN $7.5B −6.7% — 4.8% 6.5% 16.9x 5 Compare →
International Flavors & Fragrances IFF $24.2B −5.2% −3.5% 2.4% −1.4% 82.6x 6 Compare →
Westlake WLK $8.3B −8.0% −14.1% −4.7% −10.0% — 3 Compare →
RPM International RPM $12.6B 6.7% — 8.6% 13.9% 18.3x 6 Compare →

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $5.4B $6.1B $7.2B $6.3B $5.7B $8.5B $9.7B $10.9B $10.3B $9.5B
Gross profit $1.4B $1.5B $2.0B $1.6B $1.3B $2.7B $2.4B $2.6B $2.3B $2.0B
Research and development $78.0M $73.0M $72.0M $67.0M $74.0M $86.0M $112M $146M $130M $125M
Operating income $934M $857M $1.3B $834M $664M $1.9B $1.4B $1.7B −$720M −$786M
Interest expense $120M $122M $125M $115M $109M $91.0M $405M $720M $676M $701M
Pretax income $1.0B $1.1B $1.5B $988M $2.3B $2.2B $1.4B $1.2B −$1.0B −$1.2B
Income tax $122M $213M $292M $124M $247M $330M −$489M −$795M $507M −$90.0M
Net income $900M $843M $1.2B $852M $2.0B $1.9B $1.9B $1.9B −$1.5B −$1.2B
Diluted EPS $6.18 $6.09 $8.91 $6.84 $16.75 $16.86 $17.34 $17.76 −$14.11 −$10.64
Diluted shares 0.15B 0.14B 0.14B 0.12B 0.12B 0.11B 0.11B 0.11B 0.11B 0.11B
Cash flow
Cash from operations $893M $803M $1.6B $1.5B $1.3B $1.8B $1.8B $1.9B $966M $1.1B
Capital expenditure $246M $267M $337M $370M $364M $467M $543M $568M $435M $343M
Free cash flow $647M $536M $1.2B $1.1B $979M $1.3B $1.3B $1.3B $531M $803M
Depreciation and amortization $290M $305M $343M $352M $350M $371M $462M $706M $801M $760M
Stock-based compensation $31.0M $47.0M $71.0M $48.0M $28.0M $95.0M $60.0M $40.0M $32.0M $24.0M
Acquisitions $178M $269M $144M $91.0M $100M $1.1B $10.6B $52.0M $0.0M $0.0M
Share buybacks $500M $500M $805M $996M $650M $1.0B $17.0M $0.0M $0.0M $0.0M
Dividends paid $201M $241M $280M $300M $293M $304M $297M $305M $307M $13.0M
Dividends and buybacks $701M $741M $1.1B $1.3B $943M $1.3B $314M $305M $307M $13.0M
Balance sheet
Cash and short-term investments $668M $608M $470M $503M $1.5B $546M $1.5B $1.8B $962M $1.3B
Total debt $3.0B $3.5B $3.4B $3.5B $3.7B $3.8B $14.5B $13.5B $12.6B $12.7B
Finance lease liabilities $0.0M $0.0M $167M $144M $201M $173M $172M $148M $145M $129M
Current assets $2.5B $2.8B $2.9B $2.8B $3.8B $3.8B $6.6B $6.2B $5.1B $5.7B
Current liabilities $1.1B $1.6B $1.8B $1.8B $2.0B $2.5B $4.1B $4.1B $3.9B $3.7B
Inventory $720M $900M $1.0B $1.0B $978M $1.5B $2.8B $2.4B $2.3B $2.2B
Property and equipment, net $3.6B $3.8B $3.7B $3.7B $3.9B $4.2B $5.6B $5.6B $5.3B $5.1B
Total assets $8.4B $9.5B $9.3B $9.5B $10.9B $12.0B $26.3B $26.6B $22.8B $21.7B
Total liabilities $5.3B $6.2B $5.9B $6.6B $7.0B $7.4B $20.2B $19.1B $17.3B $17.2B
Shareholders' equity $2.6B $2.9B $3.0B $2.5B $3.5B $4.2B $5.6B $7.1B $5.1B $4.0B
Margins
Gross margin 26.1% 24.6% 27.6% 25.5% 22.9% 31.4% 24.6% 23.6% 22.8% 20.5%
Operating margin 17.3% 14.0% 18.6% 13.2% 11.7% 22.8% 14.3% 15.2% −7.0% −8.2%
EBITDA margin 22.7% 18.9% 23.4% 18.8% 17.9% 27.1% 19.0% 21.7% 0.8% −0.3%
Net margin 16.7% 13.7% 16.9% 13.5% 35.1% 22.1% 19.6% 17.8% −15.0% −12.2%
FCF margin 12.0% 8.7% 17.1% 17.2% 17.3% 15.1% 13.2% 12.2% 5.2% 8.4%
Returns
Return on capital 16.8% 11.9% 17.0% 11.6% 9.5% 23.2% 10.1% 8.6% −3.1% −3.7%
Return on capital employed 13.1% 11.2% 17.2% 10.9% 8.0% 21.2% 8.7% 7.4% −3.5% −4.3%
Return on equity 36.3% 30.8% 41.1% 31.0% 65.8% 49.0% 38.6% 30.6% −25.3% −25.4%
Return on assets 10.6% 9.4% 12.8% 9.1% 19.5% 16.5% 9.9% 7.4% −6.2% −5.2%
Growth
Revenue growth −5.0% 13.9% 16.5% −12.0% −10.2% 51.0% 13.3% 13.0% −6.0% −7.1%
Net income growth 196.1% −6.3% 43.2% −29.4% 133.0% −4.8% 0.2% 2.6% −179.4% —
EPS growth 209.0% −1.5% 46.3% −23.2% 144.9% 0.7% 2.9% 2.4% −179.5% —
FCF growth 2.7% −17.2% 127.8% −11.2% −9.7% 31.8% −1.1% 4.3% −60.1% 51.2%
Share count change −4.4% −5.1% −2.1% −8.0% −5.0% −5.4% −2.5% 0.1% −0.1% 0.2%
Financial health
Net debt / EBITDA 1.9x 2.5x 1.9x 2.7x 2.4x 1.5x 7.1x 5.0x 145.2x —
Debt / equity 1.2x 1.2x 1.2x 1.5x 1.1x 1.0x 2.6x 1.9x 2.5x 3.2x
Interest coverage 7.8x 7.0x 10.7x 7.3x 6.1x 21.4x 3.4x 2.3x −1.1x −1.1x
Current ratio 2.3x 1.8x 1.6x 1.6x 1.9x 1.5x 1.6x 1.5x 1.3x 1.6x
Quick ratio 1.6x 1.2x 1.0x 1.0x 1.4x 0.9x 0.9x 1.0x 0.7x 0.9x
Capital allocation
Capex / revenue 4.6% 4.4% 4.7% 5.9% 6.4% 5.5% 5.6% 5.2% 4.2% 3.6%
Stock comp / revenue 0.6% 0.8% 1.0% 0.8% 0.5% 1.1% 0.6% 0.4% 0.3% 0.3%
Payouts / FCF 108.4% 138.3% 88.9% 119.6% 96.3% 101.1% 24.6% 22.9% 57.8% 1.6%
Quality scores
Piotroski F-score 6.0 4.0 8.0 4.0 6.0 6.0 5.0 3.0 4.0 5.0
Altman Z'' 4.1 3.7 4.4 4.0 4.5 5.1 2.7 3.0 2.1 2.1
Accruals ratio 0.1% 0.5% −3.7% −6.4% 6.3% 1.2% 0.4% 0.2% −10.2% −10.4%

Source: SEC EDGAR XBRL filings (CIK 0001306830). Data updated October 21, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move · ↵ to open